Antibiotic and processes for its manufacture
CA 1079213 A · Owner: Ciba-Geigy Ag · Inventors: Zahner, Hans; Keller, Walter; Drautz, Hannelore
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to the new antibiotic Lysolipin including two components X and I, and derivatives thereof. Lysolipin is formed when the strain Streptomyces violaceoniger (Waksman et Curtis) Waksman et Henrici T? 96 which strain has, been deposited under the reference NRRL 8097 at the Northern Regional Laboratory, U.S. Department of Agriculture Peoria, Illinois, is cultured in a nutrient medium. The structure of Lysolipin I has been elucidated; it has the formula Lysolipin and its derivatives have antibacterial action and an action against yeast - like fungi, such as Candida albicans. Its antibiotic action probably depends on an inhibition of the cell wall synthesis.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted June 10, 1980. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended June 10, 1997.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.